Literature DB >> 2789117

Impaired mitogen responses of the non-leukaemic B cells from patients with chronic lymphocytic leukaemia.

A Morgan1, J Eaves, J W Mockford, V Malkovska.   

Abstract

We investigated the immunological mechanism of the low level of circulating immunoglobulin and depressed primary and secondary responses of patients with chronic lymphocytic leukaemia (B-CLL) using purified non-leukaemic B cells in vitro. To assess the function of the non-leukaemic B cells we separated them from the much larger leukaemic population, which expresses the pan-T cell marker CD5, by immunoabsorption using anti-CD5 antibodies and Dynabeads. Immunoglobulin production was measured after the cells had been cultured with the B cell mitogens, pokeweed mitogen (PWM) and Staphylococcus aureus Cowan strain 1 (SAC). Autologous T cells that were found to function normally in our systems were added to cultures containing PWM. Non-leukaemic B cells from 15 B-CLL patients produced 539 ng/ml, immunoglobulin (mean value) with SAC and 162 ng/ml with PWM compared with 14,182 and 5513 ng/ml, respectively, from B cells from normal, age-matched control patients. Most of the immunoglobulin produced in the non-leukaemic B cell cultures carried the light chain associated with the leukaemic clone. We conclude that even at early stages in the disease (12 patients were Rai stage 0 patients) when the total serum immunoglobulin levels are still near normal, the B cells respond poorly to B cell mitogens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789117      PMCID: PMC1541984     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

2.  IMMUNOLOGICAL DEFICIENCY DISORDERS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND MULTIPLE MYELOMA.

Authors:  L CONE; J W UHR
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

3.  Clinical correlations with immunoglobulin levels in chronic lymphatic leukaemia.

Authors:  P Fiddes; R Penny; J V Wells; M C Rozenberg
Journal:  Aust N Z J Med       Date:  1972-11

Review 4.  Surface markers in chronic lymphoid leukemias of B cell type.

Authors:  F Caligaris-Cappio; G Janossy
Journal:  Semin Hematol       Date:  1985-01       Impact factor: 3.851

5.  Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies.

Authors:  C D Platsoucas; M Galinski; S Kempin; L Reich; B Clarkson; R A Good
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

6.  Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type.

Authors:  F Herrmann; G Sieber; Z Chen; B Enders; B Komischke; H Rühl
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

7.  Lymphocyte response to pokeweed mitogen in chronic lymphocytic leukemia.

Authors:  H V Lamberson; F R Davey; C M Schreck; K Zamkoff; A S Kurec
Journal:  Cancer       Date:  1984-06-01       Impact factor: 6.860

8.  T-lymphocyte subpopulations in chronic lymphocytic leukemia: a quantitative and functional study.

Authors:  G Semenzato; A Pezzutto; C Agostini; M Albertin; G Gasparotto
Journal:  Cancer       Date:  1981-11-15       Impact factor: 6.860

9.  Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.

Authors:  R Foa; F Lauria; P Lusso; M C Giubellino; M T Fierro; M L Ferrando; D Raspadori; L Matera
Journal:  Br J Haematol       Date:  1984-11       Impact factor: 6.998

10.  Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population.

Authors:  R Foa; M Giovarelli; C Jemma; M T Fierro; P Lusso; M L Ferrando; F Lauria; G Forni
Journal:  Blood       Date:  1985-09       Impact factor: 22.113

View more
  1 in total

1.  Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes.

Authors:  A M Walker; D W Montgomery; S Saraiya; T W Ho; H S Garewal; J Wilson; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.